Connor Clark & Lunn Investment Management Ltd. Invests $1.15 Million in Balchem Co. (NASDAQ:BCPC)

Connor Clark & Lunn Investment Management Ltd. acquired a new position in shares of Balchem Co. (NASDAQ:BCPC) in the 3rd quarter, HoldingsChannel reports. The fund acquired 6,550 shares of the basic materials company’s stock, valued at approximately $1,153,000.

Several other large investors also recently modified their holdings of the stock. Conestoga Capital Advisors LLC boosted its holdings in Balchem by 1.8% during the 3rd quarter. Conestoga Capital Advisors LLC now owns 1,175,569 shares of the basic materials company’s stock worth $206,900,000 after acquiring an additional 20,360 shares during the last quarter. Geneva Capital Management LLC boosted its holdings in Balchem by 1.7% during the 3rd quarter. Geneva Capital Management LLC now owns 779,869 shares of the basic materials company’s stock worth $137,257,000 after acquiring an additional 12,750 shares during the last quarter. Dimensional Fund Advisors LP boosted its holdings in Balchem by 0.9% during the 2nd quarter. Dimensional Fund Advisors LP now owns 697,461 shares of the basic materials company’s stock worth $107,372,000 after acquiring an additional 5,977 shares during the last quarter. Congress Asset Management Co. boosted its holdings in Balchem by 12.4% during the 3rd quarter. Congress Asset Management Co. now owns 301,440 shares of the basic materials company’s stock worth $53,053,000 after acquiring an additional 33,373 shares during the last quarter. Finally, Bank of New York Mellon Corp boosted its holdings in Balchem by 1.2% during the 2nd quarter. Bank of New York Mellon Corp now owns 277,475 shares of the basic materials company’s stock worth $42,717,000 after acquiring an additional 3,279 shares during the last quarter. Institutional investors and hedge funds own 87.91% of the company’s stock.

Analyst Upgrades and Downgrades

A number of equities analysts have issued reports on BCPC shares. HC Wainwright lifted their price objective on shares of Balchem from $185.00 to $190.00 and gave the stock a “buy” rating in a report on Monday, November 4th. StockNews.com raised shares of Balchem from a “hold” rating to a “buy” rating in a report on Monday, October 28th.

Balchem Trading Down 1.4 %

NASDAQ BCPC opened at $179.69 on Thursday. The stock has a market capitalization of $5.84 billion, a price-to-earnings ratio of 48.30, a PEG ratio of 5.46 and a beta of 0.65. Balchem Co. has a one year low of $120.87 and a one year high of $186.03. The company has a debt-to-equity ratio of 0.21, a current ratio of 2.98 and a quick ratio of 1.90. The business’s fifty day moving average is $174.23 and its 200-day moving average is $167.08.

About Balchem

Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets worldwide. It operates through three segments: Human Nutrition and Health, Animal Nutrition and Health, and Specialty Products.